Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Messenger RNA Engineered to Produce Antibodies

Academic and industry researchers demonstrated production of therapeutic antibodies inside cells of lab mice, offering a simpler and lower-cost alternative to monoclonal antibodies. . . . → Read More: Messenger RNA Engineered to Produce Antibodies

Public Access to Drugs Meets Health Needs, Cuts Costs

A study shows adding universal access to essential drugs as part of Canada’s health care system would meet much of that country’s pharmaceutical needs and save billions of dollars. . . . → Read More: Public Access to Drugs Meets Health Needs, Cuts Costs

Nuclear Cancer Therapy Company Launches, Raises $25M

A new company developing cancer therapies combining nuclear radiation and synthetic antibodies is starting up in Hamilton, Ontario. . . . → Read More: Nuclear Cancer Therapy Company Launches, Raises $25M

Slot Machine Gamblers Get Hooked in Trance-Like State

Findings from a recent study show gamblers who get immersed in playing slot machines are more at risk to develop gambling problems as a result. . . . → Read More: Slot Machine Gamblers Get Hooked in Trance-Like State

Novo Nordisk to Open Oxford Diabetes Research Center

The pharmaceutical company Novo Nordisk will build a research center to study type 2 diabetes on the campus of University of Oxford in the U.K. . . . → Read More: Novo Nordisk to Open Oxford Diabetes Research Center

Cell Biotech Gains Organoid Technology

A Canadian biotechnology enterprise is licensing a technology that generates organoids, three-dimensional clusters of cells from stem cells that can form into gastrointestinal organs. . . . → Read More: Cell Biotech Gains Organoid Technology

Peptide-Infused Gel Shown to Heal Chronic Wounds

A tissue engineering group developed a gel material infused with a synthetic peptide that in lab cultures and animals healed chronic diabetic wounds faster than a current commercial treatment. . . . → Read More: Peptide-Infused Gel Shown to Heal Chronic Wounds

Stem Cell Therapy Company Formed, Staked to $225M

A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells. . . . → Read More: Stem Cell Therapy Company Formed, Staked to $225M

Commercial Genome Service Launches Based on Open Data

A start-up software company is offering genetic analysis services for research and precision medicine that comply with open standards and access Google’s genomic data sets. . . . → Read More: Commercial Genome Service Launches Based on Open Data

University Spin-Off Developing Sepsis Drug

A spin-off enterprise from University of British Columbia is licensing a cholesterol-lowering drug from drug maker Novartis to develop a treatment for sepsis and other severe infections. . . . → Read More: University Spin-Off Developing Sepsis Drug